Remedent Stock Price, News & Analysis
Company Description
Remedent (OTC Link: REMI) is a publicly traded medical instruments & supplies company in the Healthcare sector. The company has a market capitalization of $200.0K.
REMI stock has declined 98.6% over the past year. Shares last traded at $0.0007.
This page provides a comprehensive overview of REMI stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Remedent (REMI) stock last traded at $0.0007. Over the past 12 months, the stock has lost 98.6%. At a market capitalization of $200.0K, REMI is classified as a micro-cap stock with approximately 20.0M shares outstanding.
Latest News
Remedent has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all REMI news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
REMI Company Profile & Sector Positioning
Remedent (REMI) operates in the Medical Instruments & Supplies industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing REMI often look at related companies in the same sector, including Hear Atlast Holdings (HRAL), Wearable Health (WHSI), Innerscope Hear (INND), Biolife Sciences Inc (BLFE), and Tevano Systems H (TEVNF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate REMI's relative position within its industry.